Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The anxiolytic effects of cannabidiol in chronically stressed mice are mediated by the endocannabinoid system: Role of neurogenesis and dendritic remodeling
Manoela V. Fogaça, Alline C. Campos, Ludmila D. Coelho, et al.
Neuropharmacology (2018) Vol. 135, pp. 22-33
Closed Access | Times Cited: 183

Showing 1-25 of 183 citing articles:

Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain
Danilo De Gregorio, Ryan J. McLaughlin, Luca Posa, et al.
Pain (2018) Vol. 160, Iss. 1, pp. 136-150
Open Access | Times Cited: 313
Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions
Manoela V. Fogaça, Ronald S. Duman
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 310
Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial
Yasmin L. Hurd, Sharron Spriggs, Julia Alishayev, et al.
American Journal of Psychiatry (2019) Vol. 176, Iss. 11, pp. 911-922
Closed Access | Times Cited: 278
Immune Responses Regulated by Cannabidiol
James M. Nichols, Barbara L.F. Kaplan
Cannabis and Cannabinoid Research (2019) Vol. 5, Iss. 1, pp. 12-31
Open Access | Times Cited: 235
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
María S. García‐Gutiérrez, Francisco Navarrete, Ani Gasparyan, et al.
Biomolecules (2020) Vol. 10, Iss. 11, pp. 1575-1575
Open Access | Times Cited: 210
Clinicians’ Guide to Cannabidiol and Hemp Oils
Harrison VanDolah, Brent A. Bauer, Karen F. Mauck
Mayo Clinic Proceedings (2019) Vol. 94, Iss. 9, pp. 1840-1851
Open Access | Times Cited: 198
Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex
Amanda J. Sales, Manoela V. Fogaça, Ariandra Guerini Sartim, et al.
Molecular Neurobiology (2018) Vol. 56, Iss. 2, pp. 1070-1081
Closed Access | Times Cited: 172
Amygdala-hippocampal innervation modulates stress-induced depressive-like behaviors through AMPA receptors
Hui Ma, Chenyang Li, Jinpeng Wang, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 6
Open Access | Times Cited: 104
Cannabidiol (CBD) use in psychiatric disorders: A systematic review
Stefania Bonaccorso, A Ricciardi, Caroline Zangani, et al.
NeuroToxicology (2019) Vol. 74, pp. 282-298
Open Access | Times Cited: 142
Cannabinoids, Blood–Brain Barrier, and Brain Disposition
Fabrizio Calapai, Luigi Cardia, Emanuela Elisa Sorbara, et al.
Pharmaceutics (2020) Vol. 12, Iss. 3, pp. 265-265
Open Access | Times Cited: 95
Opportunities for cannabis in supportive care in cancer
Amber S. Kleckner, Ian R. Kleckner, Charles Kamen, et al.
Therapeutic Advances in Medical Oncology (2019) Vol. 11
Open Access | Times Cited: 82
Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms
Gabriela Pandini Silote, Ariandra Guerini Sartim, Amanda J. Sales, et al.
Journal of Chemical Neuroanatomy (2019) Vol. 98, pp. 104-116
Closed Access | Times Cited: 76
Sericin alleviates restraint stress induced depressive- and anxiety-like behaviors via modulation of oxidative stress, neuroinflammation and apoptosis in the prefrontal cortex and hippocampus
Ahad Banagozar Mohammadi, Mohammadali Torbati, Fereshteh Farajdokht, et al.
Brain Research (2019) Vol. 1715, pp. 47-56
Closed Access | Times Cited: 76
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis
Elizabeth Appiah‐Kusi, Natalia Petros, Rebecca Wilson, et al.
Psychopharmacology (2020) Vol. 237, Iss. 4, pp. 1121-1130
Open Access | Times Cited: 75
Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors
Naielly Rodrigues da Silva, Felipe V. Gomes, Andreza B. Sonego, et al.
Pharmacological Research (2020) Vol. 156, pp. 104749-104749
Open Access | Times Cited: 71
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Francisco Navarrete, María S. García‐Gutiérrez, Ani Gasparyan, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 59
Endocannabinoids, cannabinoids and the regulation of anxiety
Gavin N. Petrie, Andrei S. Nastase, Robert J. Aukema, et al.
Neuropharmacology (2021) Vol. 195, pp. 108626-108626
Closed Access | Times Cited: 57
Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration
Grace Tsz Yan Yau, Waiting Tai, Jonathon C. Arnold, et al.
Pharmaceutical Research (2023) Vol. 40, Iss. 5, pp. 1087-1114
Open Access | Times Cited: 26
Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders
Maria de Fátima dos Santos Sampaio, Yara Bezerra de Paiva, Tuane Bazanella Sampaio, et al.
Basic & Clinical Pharmacology & Toxicology (2024) Vol. 134, Iss. 5, pp. 574-601
Open Access | Times Cited: 11
Exploring the Anxiolytic, Antidepressant, and Immunomodulatory Effects of Cannabidiol in Acute Stress Rat Models
H. Zlatanova, Maria Georgieva-Kotetarova, N. Vilmosh, et al.
Applied Biosciences (2025) Vol. 4, Iss. 1, pp. 4-4
Open Access | Times Cited: 1
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia
Tibor Štark, Jana Kučerová, Fabio Arturo Iannotti, et al.
Neuropharmacology (2018) Vol. 146, pp. 212-221
Closed Access | Times Cited: 76
N-Methyl-D-aspartate receptor antagonist d-methadone produces rapid, mTORC1-dependent antidepressant effects
Manoela V. Fogaça, Kenichi Fukumoto, Tina Franklin, et al.
Neuropsychopharmacology (2019) Vol. 44, Iss. 13, pp. 2230-2238
Open Access | Times Cited: 73
Development of a validated method for the qualitative and quantitative analysis of cannabinoids in plant biomass and medicinal cannabis resin extracts obtained by super-critical fluid extraction
Aaron Elkins, Myrna A. Deseo, Simone Rochfort, et al.
Journal of Chromatography B (2019) Vol. 1109, pp. 76-83
Closed Access | Times Cited: 65
Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis
Aisling O’Neill, Robin Wilson, Grace Blest‐Hopley, et al.
Psychological Medicine (2020) Vol. 51, Iss. 4, pp. 596-606
Closed Access | Times Cited: 63
Cannabidiol attenuates aggressive behavior induced by social isolation in mice: Involvement of 5-HT1A and CB1 receptors
Alice Hartmann dos Santos, Sabrina F. Lisboa, Andreza B. Sonego, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 94, pp. 109637-109637
Closed Access | Times Cited: 54
Page 1 - Next Page

Scroll to top